No worries. Just thought I would state that A2M is back to today's high and BAL is heading to today's lows.Shorting BAL was a safe bet.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025